Eli Lilly seems to have responded to the threat ... and reduced investment in R&D. Lilly's announcement comes just a few days after Lilly's chief executive, David Ricks, and other pharma leaders ...

Cambridge life science game-changer ViaNautis has long caught the eye as one of the sector's most exciting companies and ...

Eli Lilly has ... facility on Lilly’s campus in Indianapolis, clearing one of the key obstacles to entering the radiopharma category, and also operates an R&D unit in Toronto, Canada.

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have ...

Eli Lilly (NYSE:LLY) reported its Q1 2025 earnings ... The thing is that the revenue it spends in terms of its R&D is not all that much. R&D spends only accounts for 21.5% of revenue at the ...

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal focused on treating hearing loss. The centerpiece of the agreement is ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/ ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

TL;DR: NVIDIA plans to build a new R&D facility in Shanghai to navigate US export restrictions and stay competitive in China’s AI GPU market. The center will focus on local customer needs ...

So far, there is nothing concrete on paper,” he said. Dhanuka has set up its research and development (R&D) facility at Sanand in Gujarat, where 30 scientists are working. If the scientists ...

We’re excited to open our Plano production facility in partnership with the City of Plano and the State of Texas to augment our next-generation R&D facility in Rio Rancho, New Mexico.